Candel Therapeutics Ownership | Who Owns Candel Therapeutics?
Candel Therapeutics Ownership Summary
Candel Therapeutics is owned by 13.90% institutional investors, 16.76% insiders, and 69.34% retail investors. Fmr is the largest institutional shareholder, holding 15.99% of CADL shares. Fidelity Select Biotechnology is the top mutual fund, with 10.10% of its assets in Candel Therapeutics shares.
CADL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Candel Therapeutics | 13.90% | 16.76% | 69.34% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 8.23M | 15.99% | $41.99M |
| Northpond ventures | 1.94M | 6.63% | $12.00M |
| Acorn capital advisors | 2.58M | 5.01% | $13.16M |
| Blackrock funding, inc. /de | 2.38M | 4.62% | $12.13M |
| Vanguard group | 2.01M | 3.90% | $10.24M |
| Blackrock | 823.07K | 2.82% | $5.10M |
| Portolan capital management | 1.38M | 2.69% | $7.06M |
| Geode capital management | 928.20K | 1.80% | $4.73M |
| Halter ferguson financial | 698.00K | 1.36% | $3.56M |
| State street | 688.77K | 1.34% | $3.51M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Northpond ventures | 1.94M | 21.71% | $12.00M |
| Acorn capital advisors | 2.58M | 6.68% | $13.16M |
| Halter ferguson financial | 698.00K | 0.81% | $3.56M |
| Sands capital ventures | 405.84K | 0.45% | $2.07M |
| Portolan capital management | 1.38M | 0.38% | $7.06M |
| Birchview capital, lp | 60.00K | 0.23% | $306.00K |
| Tanager wealth management llp | 198.18K | 0.11% | $1.01M |
| Taylor financial group | 13.60K | 0.04% | $69.36K |
| Entrypoint capital | 18.70K | 0.04% | $95.35K |
| Virtu financial | 22.64K | 0.01% | $140.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 823.07K | 0.00% | 775.49K |
| Vanguard group | 2.01M | 0.00% | 219.56K |
| Susquehanna group, llp | 294.44K | 0.00% | 158.99K |
| Nuveen | 209.66K | 0.00% | 117.18K |
| Kovitz investment group partners | 79.32K | 0.00% | 79.32K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -1.60M |
| Baker bros. advisors lp | - | - | -355.11K |
| Portolan capital management | 1.38M | 0.38% | -237.59K |
| Two sigma investments, lp | 136.12K | 0.00% | -233.08K |
| Franklin resources | - | - | -211.01K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Kovitz investment group partners | 79.32K | 0.00% | 79.32K | $404.51K |
| Lido advisors | 60.20K | 0.00% | 60.20K | $307.02K |
| State of wisconsin investment board | 54.05K | 0.00% | 54.05K | $275.64K |
| Virtu financial | 22.64K | 0.01% | 22.64K | $140.00K |
| Citadel advisors | 14.30K | - | 14.30K | $88.66K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -1.00 |
| National bank of canada /fi/ | -3.00 |
| True wealth design | -8.00 |
| Signaturefd | -39.00 |
| Allworth financial lp | -45.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 36 | -56.63% | 7,158,075 | -68.93% | 13 | 0.26% | 20 | -64.91% | 9 | -40.00% |
| Jun 30, 2025 | 83 | -5.68% | 23,028,788 | 8.68% | 72 | 4.13% | 56 | -11.11% | 16 | 33.33% |
| Mar 31, 2025 | 88 | 12.82% | 21,199,863 | 18.25% | 41 | 1.34% | 63 | 16.67% | 12 | 50.00% |
| Dec 31, 2024 | 22 | -60.71% | 2,942,258 | -56.04% | 9 | 2.10% | 15 | -51.61% | 4 | -60.00% |
| Sep 30, 2024 | 56 | 14.29% | 6,693,231 | 12.27% | 20 | 5.01% | 31 | -26.19% | 10 | 150.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 5.54M | 10.10% | - |
| Fidelity Growth Compy Commingled Pl S | 1.24M | 2.25% | 1.70K |
| Vanguard Total Stock Mkt Idx Inv | 1.08M | 2.16% | 217.04K |
| iShares Russell 2000 ETF | 940.31K | 1.71% | - |
| Fidelity Growth Company Fund | 907.97K | 1.65% | -5.43K |
| Strategic Advisers U.S. Total Stock | 878.66K | 1.60% | 257.57K |
| BANOR SICAV Rosemary S EUR Acc | 440.00K | 0.88% | 80.00K |
| Vanguard Institutional Extnd Mkt Idx Tr | 389.28K | 0.78% | -177.38K |
| Fidelity Small Cap Index | 394.96K | 0.72% | 104.90K |
| iShares Russell 2000 Growth ETF | 311.51K | 0.57% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 28, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | $6.54K |
| Jun 30, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | $3.94K |
| Mar 18, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | $397.00K |
| Mar 18, 2025 | Barone Francesca | Chief Scientific Officer | Sell | $281.67K |
| Mar 18, 2025 | Tak Paul Peter | Chief Executive Officer | Sell | $226.02K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 16 |
| 2024 Q4 | 2 | 10 |
| 2024 Q3 | - | 10 |
CADL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools